Allergan adjunctive therapy to anti-VEGF
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allergan adjunctive therapy to anti-VEGF, covering 2012-09-03 to 2012-09-03. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD) [Phase 2]